{"title":"Agilent Technologies Agrees to Acquire Dako for US$2.2 B in its Largest Deal to Date","authors":"Heather Cartwright","doi":"10.3833/PDR.V2012I5.1744","DOIUrl":null,"url":null,"abstract":"Agilent Technologies has agreed to buy the Danish cancer diagnostics company Dako, which is currently owned by the Swedish private equity group EQT Partners, for US$2.2 B. The acquisition, which represents the largest deal in Agilent’s history, is the company’s latest attempt to expand its life sciences business and will complement its existing diagnostics portfolio.","PeriodicalId":19951,"journal":{"name":"Pharmadeals Review","volume":"2 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2012-05-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Pharmadeals Review","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.3833/PDR.V2012I5.1744","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
Abstract
Agilent Technologies has agreed to buy the Danish cancer diagnostics company Dako, which is currently owned by the Swedish private equity group EQT Partners, for US$2.2 B. The acquisition, which represents the largest deal in Agilent’s history, is the company’s latest attempt to expand its life sciences business and will complement its existing diagnostics portfolio.
京公网安备 11010802042870号
京ICP备2023020795号-1
分享
求助内容：
应助结果提醒方式：
扫码关注我们
